Innoveren Scientific Inc.

As of September 30, 2023, Innoveren Scientific Inc. carries a market capitalization of 240,545.39, placing it among publicly traded companies globally. Its enterprise value stands at 4.57M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of September 30, 2023, Innoveren Scientific Inc. has 712,170.00 shares outstanding.

These figures are as of September 30, 2023.

As of September 30, 2023, Innoveren Scientific Inc. maintains a current ratio of 0.08, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -40.76, indicating conservative leverage, while an interest coverage ratio of -6.56 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended September 30, 2023. Return on assets (ROA) is negative at -632.82, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 2.00, a quick read on workforce productivity versus industry peers.

As of the close on October 7, 2026, Innoveren Scientific Inc.'s stock has gained approximately 50.00% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.68.

Over the twelve months ended September 30, 2023, Innoveren Scientific Inc. generated - - in revenue and converted that into -3.26M in net income, yielding earnings per share of -4.36. EBITDA reached -2.87M, while operating income came in at -2.09M.

As of September 30, 2023, Innoveren Scientific Inc. holds 543,882.00 in cash and equivalents against 4.44M in total debt, resulting in a net debt position of 3.88M. Total book value stands at -11.33M, with working capital of -8.91M providing operational flexibility.

Innoveren Scientific Inc. produced -918,105.00 in operating cash flow over the twelve months ended September 30, 2023. After subtracting - - in capital expenditures, free cash flow totaled -918,105.00 - equivalent to -1.44 per share.

These figures cover the twelve months ended September 30, 2023. Free cash flow yield is negative at -363.69: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -231.15, meaning Innoveren Scientific Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Innoveren Scientific Inc.'s most recent stock split took place on July 5, 2022 with a 1000:1 split ratio.

As of September 30, 2023, Innoveren Scientific Inc. has an Altman Z-Score of -130.63, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.